Sponsored Links
| Data From Phase 3 Studies Of Investigational Fixed-Dose Combination Of Azilsartan Medoxomil Plus Chlorthalidone |
 |
 |
 |
| Medical News - Hypertension | |||
|
Takeda Global Research & Development Center, Inc. U.S., (TGRD U.S.) today announced results from three phase 3 studies of the investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone (CLD)... Read more: Hypertension News From Medical News Today
|